FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076494306> ?p ?o ?g. }

• W2076494306 endingPage "747" @default.
• W2076494306 startingPage "739" @default.
• W2076494306 abstract "The purpose of this study was to evaluate 1-year functional and structural effects of intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to pathologic myopia (myopic choroidal neovascularization).Fifteen eyes with myopic choroidal neovascularization participated in this prospective interventional, noncomparative case series. All patients were treated with one intravitreal injection of 1.25 mg bevacizumab. Retreatments were performed in case of persistent or recurrent leakage on fluorescein angiography and/or intraretinal fluid on optical coherence tomography. Evaluation of best-corrected visual acuity using Early Treatment of Diabetic Retinopathy Study criteria, MP-1 microperimetry, optical coherence tomography, and fluorescein angiography were performed before treatment and 1 month, 3 months, 6 months, and 1 year after treatment.After a follow-up of 12 months, best-corrected visual acuity improved on average of 0.23 logarithm of the minimum angle of resolution. Mean macular sensitivity within the central 8 degrees increased on average of 2.62 dB at 12-month postinjection. The mean number of measurement points within the central absolute scotoma reduced significantly from 12.47 before treatment to 6.27 at 1-year follow-up. An improvement of fixation stability from baseline was observed in 9 patients (60%). No treatment adverse events were evidenced.Improvement of macular sensitivity and fixation stability 1 year after intravitreal bevacizumab for myopic choroidal neovascularization suggest a stable and progressive macular function recovery. The mean treatment session was 1.53, with 53.3% of patients needing only a single intravitreal bevacizumab injection, supporting a potential long-lasting efficacy of intravitreal bevacizumab treatment." @default.
• W2076494306 created "2016-06-24" @default.
• W2076494306 creator A5000661599 @default.
• W2076494306 creator A5008372887 @default.
• W2076494306 creator A5017021924 @default.
• W2076494306 creator A5026662948 @default.
• W2076494306 creator A5046210262 @default.
• W2076494306 creator A5065454602 @default.
• W2076494306 creator A5078414485 @default.
• W2076494306 creator A5079872201 @default.
• W2076494306 creator A5091069666 @default.
• W2076494306 date "2010-05-01" @default.
• W2076494306 modified "2023-10-07" @default.
• W2076494306 title "MACULAR FUNCTIONAL CHANGES EVALUATED WITH MP-1 MICROPERIMETRY AFTER INTRAVITREAL BEVACIZUMAB FOR SUBFOVEAL MYOPIC CHOROIDAL NEOVASCULARIZATION" @default.
• W2076494306 cites W110906275 @default.
• W2076494306 cites W1965238925 @default.
• W2076494306 cites W1976409243 @default.
• W2076494306 cites W1977060039 @default.
• W2076494306 cites W1981265260 @default.
• W2076494306 cites W1989256058 @default.
• W2076494306 cites W1991064811 @default.
• W2076494306 cites W1992041797 @default.
• W2076494306 cites W1995086395 @default.
• W2076494306 cites W1999053742 @default.
• W2076494306 cites W1999592084 @default.
• W2076494306 cites W1999611557 @default.
• W2076494306 cites W2005450884 @default.
• W2076494306 cites W2017670393 @default.
• W2076494306 cites W2035215834 @default.
• W2076494306 cites W2051258987 @default.
• W2076494306 cites W2052753809 @default.
• W2076494306 cites W2060690838 @default.
• W2076494306 cites W2062091095 @default.
• W2076494306 cites W2069895573 @default.
• W2076494306 cites W2091038445 @default.
• W2076494306 cites W2097423690 @default.
• W2076494306 cites W2113355329 @default.
• W2076494306 cites W2155905635 @default.
• W2076494306 cites W2160135935 @default.
• W2076494306 cites W233579014 @default.
• W2076494306 cites W4247193020 @default.
• W2076494306 doi "https://doi.org/10.1097/iae.0b013e3181c59725" @default.
• W2076494306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20038860" @default.
• W2076494306 hasPublicationYear "2010" @default.
• W2076494306 type Work @default.
• W2076494306 sameAs 2076494306 @default.
• W2076494306 citedByCount "19" @default.
• W2076494306 countsByYear W20764943062012 @default.
• W2076494306 countsByYear W20764943062013 @default.
• W2076494306 countsByYear W20764943062014 @default.
• W2076494306 countsByYear W20764943062015 @default.
• W2076494306 countsByYear W20764943062016 @default.
• W2076494306 countsByYear W20764943062017 @default.
• W2076494306 countsByYear W20764943062018 @default.
• W2076494306 countsByYear W20764943062021 @default.
• W2076494306 crossrefType "journal-article" @default.
• W2076494306 hasAuthorship W2076494306A5000661599 @default.
• W2076494306 hasAuthorship W2076494306A5008372887 @default.
• W2076494306 hasAuthorship W2076494306A5017021924 @default.
• W2076494306 hasAuthorship W2076494306A5026662948 @default.
• W2076494306 hasAuthorship W2076494306A5046210262 @default.
• W2076494306 hasAuthorship W2076494306A5065454602 @default.
• W2076494306 hasAuthorship W2076494306A5078414485 @default.
• W2076494306 hasAuthorship W2076494306A5079872201 @default.
• W2076494306 hasAuthorship W2076494306A5091069666 @default.
• W2076494306 hasConcept C118487528 @default.
• W2076494306 hasConcept C141071460 @default.
• W2076494306 hasConcept C2776403814 @default.
• W2076494306 hasConcept C2776694085 @default.
• W2076494306 hasConcept C2777802072 @default.
• W2076494306 hasConcept C2778257484 @default.
• W2076494306 hasConcept C2779100554 @default.
• W2076494306 hasConcept C2780248432 @default.
• W2076494306 hasConcept C2781100027 @default.
• W2076494306 hasConcept C2781148688 @default.
• W2076494306 hasConcept C2781359195 @default.
• W2076494306 hasConcept C71924100 @default.
• W2076494306 hasConceptScore W2076494306C118487528 @default.
• W2076494306 hasConceptScore W2076494306C141071460 @default.
• W2076494306 hasConceptScore W2076494306C2776403814 @default.
• W2076494306 hasConceptScore W2076494306C2776694085 @default.
• W2076494306 hasConceptScore W2076494306C2777802072 @default.
• W2076494306 hasConceptScore W2076494306C2778257484 @default.
• W2076494306 hasConceptScore W2076494306C2779100554 @default.
• W2076494306 hasConceptScore W2076494306C2780248432 @default.
• W2076494306 hasConceptScore W2076494306C2781100027 @default.
• W2076494306 hasConceptScore W2076494306C2781148688 @default.
• W2076494306 hasConceptScore W2076494306C2781359195 @default.
• W2076494306 hasConceptScore W2076494306C71924100 @default.
• W2076494306 hasIssue "5" @default.
• W2076494306 hasLocation W20764943061 @default.
• W2076494306 hasLocation W20764943062 @default.
• W2076494306 hasOpenAccess W2076494306 @default.
• W2076494306 hasPrimaryLocation W20764943061 @default.
• W2076494306 hasRelatedWork W1615644543 @default.
• W2076494306 hasRelatedWork W1800286160 @default.
• W2076494306 hasRelatedWork W1987699263 @default.
• W2076494306 hasRelatedWork W1996073735 @default.

• next